Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of vonoprazan-based regimens for primary Helicobacter pylori eradication
ChiCTR2300072857Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Helicobacter pylori eradication rate. Started Jul 2023; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300072857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072857.